Sprey TERBINORM: overcome fungus easy!

The clinical course of mycosis is often complicated by the bacterial flora, so therapy should be comprehensive and include drugs with antimicrobial and anti-inflammatory effects. In studies, a high activity of external forms of terbinafine against gram-positive and gram-negative bacteria was noted (Bolotnaya M.A., 2012). The shape of the spray allows you to evenly distribute the drug over the surface of the skin. TERBINORM spray is convenient and easy to use, provides quick treatment of fungal lesions, which is especially important in the presence of large lesions or their localization in the folds of the skin, between the toes. It should be noted that in addition to the antifungal action, terbinafine has a high anti-inflammatory activity and pronounced antibacterial properties, and due to lipo- and keratophilicity, it is quickly absorbed into the skin, softening it (Klimova I.Ya. et al., 2007). The spray form has a refreshing, drying , anti-inflammatory and antipruritic effects. Another advantage of TERBINORM spray is that it is odorless, colorless and does not leave marks on clothes. The course treatment with TERBINORM spray is 7 days. The drug is used once a day, while creating therapeutic concentrations of terbinafine in the layers of the skin, which persist for up to 1 week, which is due to the post-therapeutic effect of the drug.

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design